News

Fierce Pharma4h
Another FDA mini-pause for Bayer’s menopause candidate?
After losing 3,500 employees in April—19% of its workforce due to congressional budget cuts—the FDA is now struggling to meet ...
GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval
Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...